Publication:
PPAR\(\alpha\) Deficiency in Inflammatory Cells Suppresses Tumor Growth

Thumbnail Image

Date

2007

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Kaipainen, Arja, Mark W. Kieran, Sui Huang, Catherine Butterfield, Diane Bielenberg, Gustavo Mostoslavsky, Richard Mulligan, Judah Folkman, and Dipak Panigrahy. 2007. PPAR\(\alpha\) deficiency in inflammatory cells suppresses tumor growth. PLoS ONE 2(2): e260.

Research Data

Abstract

Inflammation in the tumor bed can either promote or inhibit tumor growth. Peroxisome proliferator-activated receptor (PPAR)\(\alpha\) is a central transcriptional suppressor of inflammation, and may therefore modulate tumor growth. Here we show that PPAR\(\alpha\) deficiency in the host leads to overt inflammation that suppresses angiogenesis via excess production of the endogenous angiogenesis inhibitor thrombospondin-1 and prevents tumor growth. Bone marrow transplantation and granulocyte depletion show that PPAR\(\alpha\) expressing granulocytes are necessary for tumor growth. Neutralization of thrombospondin-1 restores tumor growth in PPAR\(\alpha\)-deficient mice. These findings suggest that the absence of PPAR\(\alpha\) activity renders inflammatory infiltrates tumor suppressive and, thus, may provide a target for inhibiting tumor growth by modulating stromal processes, such as angiogenesis.

Description

Keywords

Oncology

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories